M STACEY - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

M STACEY

Showing results (171-180 of 173) with videos related to

Pageof 18

Sort By:

You have reached the last page of results.This site can display upto 173 results.

Cancer Cell|July 7, 2007

Reduction of TRAIL-induced Mcl-1 and cIAP2 by c-Myc or sorafenib sensitizes resistant human cancer cells to TRAIL-induced deathM Stacey Ricci, Seok-Hyun Kim, Kazuhiro Ogi, et al.

The Journal of Clinical Investigation|May 21, 2010

Gata3-deficient mice develop parathyroid abnormalities due to dysregulation of the parathyroid-specific transcription factor Gcm2Irina V Grigorieva, Samantha Mirczuk, Katherine U Gaynor, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 25, 2015

FDA Approval: Belinostat for the Treatment of Patients with Relapsed or Refractory Peripheral T-cell LymphomaHyon-Zu Lee, Virginia E Kwitkowski, Pedro L Del Valle, et al.

Pageof 18

Search research articles

Showing results (171-180 of 173) with videos related to

Sort By:

Pageof 18

You have reached the last page of results.This site can display upto 173 results.

Cancer Cell|July 7, 2007

Reduction of TRAIL-induced Mcl-1 and cIAP2 by c-Myc or sorafenib sensitizes resistant human cancer cells to TRAIL-induced deathM Stacey Ricci, Seok-Hyun Kim, Kazuhiro Ogi, et al.

The Journal of Clinical Investigation|May 21, 2010

Gata3-deficient mice develop parathyroid abnormalities due to dysregulation of the parathyroid-specific transcription factor Gcm2Irina V Grigorieva, Samantha Mirczuk, Katherine U Gaynor, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 25, 2015

FDA Approval: Belinostat for the Treatment of Patients with Relapsed or Refractory Peripheral T-cell LymphomaHyon-Zu Lee, Virginia E Kwitkowski, Pedro L Del Valle, et al.

Pageof 18